Literature DB >> 21354972

Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility.

Nicolas Couturier1, Florence Bucciarelli, Ramil N Nurtdinov, Marc Debouverie, Christine Lebrun-Frenay, Gilles Defer, Thibault Moreau, Christian Confavreux, Sandra Vukusic, Isabelle Cournu-Rebeix, Robert H Goertsches, Uwe K Zettl, Manuel Comabella, Xavier Montalban, Peter Rieckmann, Frank Weber, Bertram Müller-Myhsok, Gilles Edan, Bertrand Fontaine, Lennart T Mars, Abdelhadi Saoudi, Jorge R Oksenberg, Michel Clanet, Roland S Liblau, David Brassat.   

Abstract

The tyrosine kinase 2 variant rs34536443 has been established as a genetic risk factor for multiple sclerosis in a variety of populations. However, the functional effect of this variant on disease pathogenesis remains unclear. This study replicated the genetic association of tyrosine kinase 2 with multiple sclerosis in a cohort of 1366 French patients and 1802 controls. Furthermore, we assessed the functional consequences of this polymorphism on human T lymphocytes by comparing the reactivity and cytokine profile of T lymphocytes isolated from individuals expressing the protective TYK2(GC) genotype with the disease-associated TYK2(GG) genotype. Our results demonstrate that the protective C allele infers decreased tyrosine kinase 2 activity, and this reduction of activity is associated with a shift in the cytokine profile favouring the secretion of Th2 cytokines. These findings suggest that the rs34536443 variant effect on multiple sclerosis susceptibility might be mediated by deviating T lymphocyte differentiation toward a Th2 phenotype. This impact of tyrosine kinase 2 on effector differentiation is likely to be of wider importance because other autoimmune diseases also have been associated with polymorphisms within tyrosine kinase 2. The modulation of tyrosine kinase 2 activity might therefore represent a new therapeutic approach for the treatment of autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21354972     DOI: 10.1093/brain/awr010

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  43 in total

Review 1.  The genetics of multiple sclerosis: an up-to-date review.

Authors:  Pierre-Antoine Gourraud; Hanne F Harbo; Stephen L Hauser; Sergio E Baranzini
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

2.  PRMT5-Selective Inhibitors Suppress Inflammatory T Cell Responses and Experimental Autoimmune Encephalomyelitis.

Authors:  Lindsay M Webb; Stephanie A Amici; Kyle A Jablonski; Himanshu Savardekar; Amanda R Panfil; Linsen Li; Wei Zhou; Kevin Peine; Vrajesh Karkhanis; Eric M Bachelder; Kristy M Ainslie; Patrick L Green; Chenglong Li; Robert A Baiocchi; Mireia Guerau-de-Arellano
Journal:  J Immunol       Date:  2017-01-13       Impact factor: 5.422

Review 3.  Genetic determinants of risk and progression in multiple sclerosis.

Authors:  Alessandro Didonna; Jorge R Oksenberg
Journal:  Clin Chim Acta       Date:  2015-02-04       Impact factor: 3.786

4.  An ImmunoChip study of multiple sclerosis risk in African Americans.

Authors:  Noriko Isobe; Lohith Madireddy; Pouya Khankhanian; Takuya Matsushita; Stacy J Caillier; Jayaji M Moré; Pierre-Antoine Gourraud; Jacob L McCauley; Ashley H Beecham; Laura Piccio; Joseph Herbert; Omar Khan; Jeffrey Cohen; Lael Stone; Adam Santaniello; Bruce A C Cree; Suna Onengut-Gumuscu; Stephen S Rich; Stephen L Hauser; Stephen Sawcer; Jorge R Oksenberg
Journal:  Brain       Date:  2015-03-28       Impact factor: 13.501

5.  Genetic variants associated with autoimmunity drive NFκB signaling and responses to inflammatory stimuli.

Authors:  William J Housley; Salvador D Fernandez; Kenneth Vera; Sasidhar R Murikinati; Jaime Grutzendler; Nicole Cuerdon; Laura Glick; Phillip L De Jager; Mitja Mitrovic; Chris Cotsapas; David A Hafler
Journal:  Sci Transl Med       Date:  2015-06-10       Impact factor: 17.956

Review 6.  Impact of microbes on autoimmune diseases.

Authors:  Claudia Danzer; Jochen Mattner
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2013-02-16       Impact factor: 4.291

7.  Exome sequencing identifies a novel multiple sclerosis susceptibility variant in the TYK2 gene.

Authors:  David A Dyment; M Zameel Cader; Michael J Chao; Matthew R Lincoln; Katie M Morrison; Giulio Disanto; Julia M Morahan; Gabriele C De Luca; A Dessa Sadovnick; Pierre Lepage; Alexandre Montpetit; George C Ebers; Sreeram V Ramagopalan
Journal:  Neurology       Date:  2012-06-27       Impact factor: 9.910

Review 8.  Opportunities for Translation from the Bench: Therapeutic Intervention of the JAK/STAT Pathway in Neuroinflammatory Diseases.

Authors:  Yudong Liu; Sara A Gibson; Etty N Benveniste; Hongwei Qin
Journal:  Crit Rev Immunol       Date:  2015       Impact factor: 2.214

9.  Tyrosine Kinase 2-mediated Signal Transduction in T Lymphocytes Is Blocked by Pharmacological Stabilization of Its Pseudokinase Domain.

Authors:  John S Tokarski; Adriana Zupa-Fernandez; Jeffrey A Tredup; Kristen Pike; ChiehYing Chang; Dianlin Xie; Lihong Cheng; Donna Pedicord; Jodi Muckelbauer; Stephen R Johnson; Sophie Wu; Suzanne C Edavettal; Yang Hong; Mark R Witmer; Lisa L Elkin; Yuval Blat; William J Pitts; David S Weinstein; James R Burke
Journal:  J Biol Chem       Date:  2015-03-11       Impact factor: 5.157

Review 10.  Involvement of the janus kinase/signal transducer and activator of transcription signaling pathway in multiple sclerosis and the animal model of experimental autoimmune encephalomyelitis.

Authors:  Etty N Benveniste; Yudong Liu; Braden C McFarland; Hongwei Qin
Journal:  J Interferon Cytokine Res       Date:  2014-08       Impact factor: 2.607

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.